Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

• Published in: Investigative ophthalmology & visual science 2024-11, Vol.65 (13), p.44
• Main Authors: Hanyuda, Akiko, Raita, Yoshihiko, Ninomiya, Takahiro, Hashimoto, Kazuki, Takada, Naoko, Sato, Kota, Inoue, Jin, Koshiba, Seizo, Tamiya, Gen, Narita, Akira, Akiyama, Masato, Omodaka, Kazuko, Tsuda, Satoru, Yokoyama, Yu, Himori, Noriko, Yamamoto, Yasuko, Taniguchi, Takazumi, Negishi, Kazuno, Nakazawa, Toru
• Format: Article
• Language: English
• Subjects: Aged; Disease Progression; Female; Follow-Up Studies; Glaucoma, Open-Angle - metabolism; Humans; Intraocular Pressure - physiology; Japan - epidemiology; Male; Metabolome - physiology; Metabolomics - methods; Middle Aged; Multiomics; Retrospective Studies; Risk Factors; Visual Field Tests; Visual Fields - physiology
• ISSN: 1552-5783; 1552-5783
• DOI: 10.1167/iovs.65.13.44

The purpose of this study was to investigate biologically meaningful endotypes of open-angle glaucoma (OAG) by applying unsupervised machine learning to plasma metabolites. This retrospective longitudinal cohort study enrolled consecutive patients aged ≥20 years with OAG at Tohoku University Hospital from January 2017 to January 2020. OAG was confirmed based on comprehensive ophthalmic examinations. Among the 523 patients with OAG with available clinical metabolomic data, 173 patients were longitudinally followed up for ≥2 years, with available data from ≥5 reliable visual field (VF) tests without glaucoma surgery. We collected fasting blood samples and clinical data at enrollment and nuclear magnetic resonance spectroscopy to profile 45 plasma metabolites in a targeted approach. After computing a distance matrix of preprocessed metabolites with Pearson distance, gap statistics determined the optimal number of OAG endotypes. Its risk factors, clinical presentations, metabolomic profiles, and progression rate of sector-based VF loss were compared across endotypes. Five distinct OAG endotypes were identified. The highest-risk endotype (endotype B) showed a significant faster progression of central VF loss (P = 0.007). Compared with patients with other endotypes, those with endotype B were more likely to have a high prevalence of dyslipidemia, cold extremities, oxidative stress, and low OAG genetic risk scores. Pathway analysis of metabolomic profiles implicated altered fatty acid and ketone body metabolism in this endotype, with 34 differentially enriched pathways (false discovery rate [FDR] < 0.05). Integrated metabolomic profiles identified five distinct etiologic endotypes of OAG, suggesting pathological mechanisms related with a high-risk group of central vision loss progression in the Japanese population.